Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandercock

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|May 29, 2012
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, Peter Sandercock, Joanna M Wardlaw, et al.
Trials|June 19, 2008
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic strokePeter Sandercock, Richard Lindley, Joanna Wardlaw, et al.
European Stroke Journal|August 20, 2021
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trialPeter Kelly, Christian Weimar, Robin Lemmens, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
Trials|December 2, 2011
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruitedPeter Sandercock, Richard Lindley, Joanna Wardlaw, et al.
Studies in Health Technology and Informatics|July 11, 2006
Designing for e-Health: recurring scenarios in developing grid-based medical imaging systemsJohn Geddes, Clare Mackay, Sharon Lloyd, et al.
Trials|June 6, 2015
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platformShaun Treweek, Doug G Altman, Peter Bower, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|May 29, 2012
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, Peter Sandercock, Joanna M Wardlaw, et al.
Trials|June 19, 2008
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic strokePeter Sandercock, Richard Lindley, Joanna Wardlaw, et al.
European Stroke Journal|August 20, 2021
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trialPeter Kelly, Christian Weimar, Robin Lemmens, et al.
Lancet (London, England)|September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Christina Reith, Jonathan Emberson, et al.
Trials|December 2, 2011
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruitedPeter Sandercock, Richard Lindley, Joanna Wardlaw, et al.
Studies in Health Technology and Informatics|July 11, 2006
Designing for e-Health: recurring scenarios in developing grid-based medical imaging systemsJohn Geddes, Clare Mackay, Sharon Lloyd, et al.
Trials|June 6, 2015
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platformShaun Treweek, Doug G Altman, Peter Bower, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
Pageof 14